Contact Us
|
Donate
|
News Centre
The George Institute for Global Health on Youtube
The George Institute for Global Health on Twitter
The George Institute for Global Health on Facebook
The George Institute for Global Health on Youtube
Home
About Us
Our Focus
Global Health
Our Global Sites
Australia
China
India
United Kingdom
Quick Finders
Expert
Health fact
Publications
Home
Found 6 results
2009
ADVANCE Collaborative Group
,
Writing Committee
,
Ninomiya T
,
Perkovic V
,
de Galan B
,
Zoungas S
,
Pillai A
,
Jardine M
,
Patel A
,
Cass A
et al.
. 2009.
Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes
.
J Am Soc Nephrol. 20:1813-21.[IF7.111]..
ADVANCE Collaborative Group
,
de Galan BE
,
Perkovic V
,
Ninomiya T
,
Pillai A
,
Patel A
,
Cass A
,
Neal B
,
Poulter N
,
Harrap S
et al.
. 2009.
Routine blood pressure lowering and kidney disease in type 2 diabetes
.
J Am Soc Nephrol. 20:883-92.[IF7.111].
2008
ADVANCE Collaborative Group Writing Group
,
(Writing Committee)
,
Patel A
,
MacMahon S
,
Chalmers J
,
Neal B
,
Billot L
,
Woodward M
,
Marre M
,
Cooper M
et al.
. 2008.
Intensive blood glucose control on vascular outcomes in patients with type 2 diabetes
.
N Engl J Med . 358:2560-72.[IF52.589][Grant:ADVANCE&ProgramGrant].
Chalmers J
,
[Booklet contributing authors]
,
MacMahon S
,
Neal B
,
Patel A
,
Perkovic V
,
Kengne AP
,
Colagiuri S
,
Grobbee R
,
Hamet P
et al.
. 2008.
New approaches for the prevention of vascular disease in Type 2 diabetes
.
:271-95.
Chalmers J
,
contributing authors
,
Colagiuri S
,
Cooper M
,
Grobbee R
,
Hamet P
,
Kengne AP
,
MacMahon S
,
Marre M
,
Mogensen CE
et al.
. 2008.
Prevention of vascular outcomes in type 2 diabetes: benefits of intensive blood pressure and blood glucose control with Preterax and Diamicron MR. Issue III
.
2007
Patel A
,
ADVANCE Collaborative Group
,
(Writing Committee)
,
MacMahon S
,
Chalmers J
,
Neal B
,
Woodward M
,
Billot L
,
Harrap S
,
Poulter N
et al.
. 2007.
Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial
.
Lancet . 370:829-40.[IF28.638].